V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210038058 | 210007227 | 1.76 | 91.9 | Curative (C) | 2017-03-31 | 2017-09-12 | ESPHALL TRIAL | Y | Y | 210012772 | TRIAL |
| 210038059 | 210018952 | 1.75 | 91 | Curative (C) | 2016-08-21 | 2016-09-27 | Temozolomide + RT | N | null | 210012870 | TEMOZOLOMIDE + RT |
| 210038060 | 210018955 | 1.75 | 82 | Curative (C) | 2014-02-10 | 2014-02-25 | Temozolomide + RT | N | Y | 210012887 | TEMOZOLOMIDE + RT |
| 210038061 | 210007295 | 1.75 | null | Palliative (P) | 2018-02-03 | 2018-02-07 | Trial Unspecified | N | N | 210012963 | TRIAL |
| 210038062 | 210007338 | null | 54.7 | Curative (C) | 2017-09-20 | 2017-09-20 | Trial Unspecified | N | Y | 210013032 | TRIAL |
| 210038063 | 210007354 | 1.65 | 87.3 | Unknown (U) | 2015-10-31 | 2015-11-05 | Trial Unspecified | 2 | N | 210013045 | TRIAL |
| 210038064 | 210007360 | 1.57 | 48.5 | Curative (C) | 2018-03-09 | 2018-08-28 | CNS HGG HERBY Bevacizumab | Y | 0 | 210013090 | TRIAL |
| 210038065 | 210007371 | null | 70.8 | Curative (C) | 2014-11-24 | 2015-05-27 | IBRUTINIB | N | N | 210013093 | IBRUTINIB |
| 210038066 | 210007406 | 1.61 | 87.6 | Palliative (P) | 2019-05-29 | 2019-11-12 | Lomustine | 2 | N | 210013144 | LOMUSTINE |
| 210038067 | 210007418 | 1.68 | 96 | Curative (C) | 2014-07-04 | 2014-07-08 | Rituximab | N | N | 210013173 | RITUXIMAB |
| 210038068 | 210007430 | 1.76 | 0 | Palliative (P) | 2017-01-26 | 2017-01-26 | Lomustine | 01 | N | 210013223 | LOMUSTINE |
| 210038069 | 210007463 | null | 0 | Curative (C) | 2016-11-22 | 2017-09-30 | Rituximab | N | N | 210013297 | RITUXIMAB |
| 210038070 | 210007469 | 1.63 | 58.3 | Palliative (P) | 2014-11-01 | 2016-07-28 | Lomustine | Y | N | 210013298 | LOMUSTINE |
| 210038072 | 210007513 | 1.79 | 75 | Palliative (P) | 2014-07-11 | 2014-08-26 | Bendamustine+Rituximab(Sub Courses) | N | N | 210013469 | BENDAMUSTINE + RITUXIMAB |
| 210038073 | 210019042 | 1.86 | 82.8 | Curative (C) | 2017-03-11 | 2017-04-21 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | null | N | 210013478 | FCR |
| 210038074 | 210007527 | 0 | 77.9 | Curative (C) | 2015-12-29 | 2016-02-23 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 210013481 | FCR |
| 210038075 | 210007561 | 1.73 | 78 | Neo-adjuvant (N) | 2016-10-03 | 2016-11-01 | FLAIR Trial | Y | N | 210013588 | FLAIR TRIAL |
| 210038076 | 210007592 | null | 64.8 | Palliative (P) | null | 2019-10-16 | FLAIR Trial | 01 | null | 210013640 | FLAIR TRIAL |
| 210038077 | 210019088 | 1.72 | 65.1 | Curative (C) | 2016-12-31 | 2017-01-01 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 210013727 | FCR |
| 210038078 | 210007658 | 1.67 | 106.8 | Curative (C) | 2019-03-12 | 2019-03-13 | Bendamustine+Rituximab(Sub Courses) | N | N | 210013754 | BENDAMUSTINE + RITUXIMAB |
| 210038079 | 210007670 | null | 61.2 | Curative (C) | 2013-09-19 | 2014-03-02 | ALL UKALL2003 TRIAL | N | N | 210013789 | UKALL 2003 |
| 210038080 | 210007705 | 1.58 | 60.7 | Curative (C) | 2017-05-01 | 2018-03-02 | METHOTREXATE | Y | N | 210013874 | METHOTREXATE |
| 210038081 | 210019118 | null | 46.1 | Curative (C) | 2014-09-14 | 2014-09-14 | ALL UKALL2003 B: Ph VII Maintenance | null | null | 210013914 | UKALL 2003 |
| 210038082 | 210007748 | 1.45 | 55.9 | Curative (C) | 2016-03-04 | 2016-03-04 | ALL UKALL60+ TRIAL | N | N | 210013944 | UKALL60+ |
| 210038083 | 210007765 | 1.78 | 62 | Curative (C) | 2015-11-18 | 2016-10-14 | ALL UKALL60+ TRIAL | N | N | 210013990 | UKALL60+ |
| 210038084 | 210007791 | 1.71 | 18.3 | Curative (C) | 2018-11-01 | 2018-12-02 | IDELALISIB + RITUXIMAB | 99 | N | 210014046 | IDELALISIB + RITUXIMAB |
| 210038085 | 210007810 | 1.57 | 77.7 | Disease modification (D) | 2016-01-15 | 2016-08-26 | R Chlorambucil | 02 | N | 210014068 | CHLORAMBUCIL + RITUXIMAB |
| 210038086 | 210007813 | 0 | 91.3 | Disease modification (D) | 2015-11-10 | 2016-05-31 | Imatinib 400mg | 01 | N | 210014072 | IMATINIB |
| 210038087 | 210007881 | 1.71 | 77.7 | Curative (C) | 2018-01-26 | 2018-09-25 | Chlorambucil + Pred + Rituximab | Y | N | 210014253 | CHLORAMBUCIL + RITUXIMAB |
| 210038088 | 210007917 | 1.73 | 89.9 | Curative (C) | 2015-01-02 | 2015-01-09 | IDELALISIB + RITUXIMAB | N | N | 210014311 | IDELALISIB + RITUXIMAB |
| 210038089 | 210007980 | 1.72 | 69.8 | Curative (C) | 2015-08-06 | 2016-02-19 | ALL UKALL2003 TRIAL | N | N | 210014466 | UKALL 2003 |
| 210038090 | 210008002 | 1.83 | 47.5 | Curative (C) | 2018-07-08 | 2018-07-08 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210014497 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210038091 | 210008045 | 1.63 | 57.3 | Curative (C) | 2019-10-29 | 2019-10-29 | ALL UKALL2003 TRIAL | 02 | N | 210014561 | UKALL 2003 |
| 210038092 | 210008063 | null | 59.5 | Palliative (P) | 2016-04-03 | 2016-05-03 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210014595 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210038095 | 210008137 | 1.7 | 66.7 | Curative (C) | 2014-12-11 | 2015-06-22 | Mercaptopurine | N | N | 210014747 | MERCAPTOPURINE |
| 210038096 | 210008154 | 1.82 | 66.7 | Curative (C) | 2018-05-08 | 2018-05-08 | Venetoclax | N | N | 210014775 | VENETOCLAX |
| 210038098 | 210008318 | 1.58 | 83 | null | 2016-06-16 | 2016-09-16 | Alemtuzumab(INTRAVENOUS) | N | N | 210015206 | ALEMTUZUMAB |
| 210038099 | 210008324 | 1.82 | 82 | Curative (C) | 2017-04-17 | 2017-04-17 | Mercaptopurine | N | N | 210015216 | MERCAPTOPURINE |
| 210038100 | 210008341 | 1.64 | 55.9 | Curative (C) | 2014-11-22 | 2015-09-15 | ALL Int Guide A/B/C Maint Ph V | N | null | 210015224 | ALL INTERIM GUIDELINES |
| 210038101 | 210008384 | null | null | Curative (C) | 2017-06-01 | 2017-06-20 | MERCAPTOPURINE + METHOTREXATE | 02 | N | 210015310 | MERCAPTOPURINE + METHOTREXATE |
| 210038102 | 210008535 | null | null | Curative (C) | 2018-12-06 | 2018-12-17 | null | N | N | 210015631 | CARBOPLATIN |
| 210038103 | 210008546 | null | null | Curative (C) | 2017-06-28 | 2018-01-28 | CHOP R - 21 days | Y | N | 210015677 | CHOP R |
| 210038104 | 210019410 | 1.71 | 22.1 | Palliative (P) | 2018-05-11 | 2018-05-15 | Etoposide Conditioning | N | null | 210015705 | ETOPOSIDE |
| 210038105 | 210008564 | 1.53 | 83 | Disease modification (D) | 2018-02-12 | 2018-06-25 | BLINATUMOMAB | N | N | 210015709 | BLINATUMOMAB |
| 210038106 | 210008616 | null | 69.3 | Curative (C) | 2017-06-12 | 2017-07-11 | Etoposide oral | null | null | 210015816 | ETOPOSIDE |
| 210038107 | 210019469 | 0 | 35.8 | Curative (C) | 2015-11-23 | 2015-11-26 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 210015905 | ALEMTUZUMAB |
| 210038108 | 210019478 | 1.78 | 22.5 | Disease modification (D) | 2017-01-02 | 2017-07-31 | CARBOPLATIN | 02 | N | 210015978 | CARBOPLATIN |
| 210038109 | 210019493 | 1.74 | 85 | Palliative (P) | 2017-04-15 | 2017-04-24 | Etoposide Conditioning | N | null | 210016143 | ETOPOSIDE |
| 210038111 | 210008767 | null | 17.6 | Curative (C) | 2017-09-16 | 2017-11-05 | Chlorambucil | N | N | 210016332 | CHLORAMBUCIL |
| 210038112 | 210008923 | 1.68 | null | Palliative (P) | 2019-03-27 | 2019-03-27 | MERCAPTOPURINE + METHOTREXATE | N | N | 210016939 | MERCAPTOPURINE + METHOTREXATE |